{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,5]],"date-time":"2026-01-05T22:24:05Z","timestamp":1767651845708},"reference-count":0,"publisher":"Georg Thieme Verlag KG","issue":"05","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmacopsychiatry"],"published-print":{"date-parts":[[1988,9]]},"DOI":"10.1055\/s-2007-1014678","type":"journal-article","created":{"date-parts":[[2008,11,7]],"date-time":"2008-11-07T06:45:36Z","timestamp":1226040336000},"page":"211-217","source":"Crossref","is-referenced-by-count":22,"title":["Psychostimulants, Analeptics, Nootropics: An Attempt to Differentiate and Assess Drugs Designed for the Treatment of Impaired Brain Functions"],"prefix":"10.1055","volume":"21","author":[{"given":"H.","family":"Coper","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W.","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"194","published-online":{"date-parts":[[2008,3,13]]},"container-title":["Pharmacopsychiatry"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.thieme-connect.de\/products\/ejournals\/pdf\/10.1055\/s-2007-1014678.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2017,5,22]],"date-time":"2017-05-22T18:22:04Z","timestamp":1495477324000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.thieme-connect.de\/DOI\/DOI?10.1055\/s-2007-1014678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1988,9]]},"references-count":0,"journal-issue":{"issue":"05","published-print":{"date-parts":[[1988,9]]}},"URL":"https:\/\/doi.org\/10.1055\/s-2007-1014678","relation":{},"ISSN":["0176-3679","1439-0795"],"issn-type":[{"value":"0176-3679","type":"print"},{"value":"1439-0795","type":"electronic"}],"subject":[],"published":{"date-parts":[[1988,9]]}}}